Parse Biosciences secures $50m in Series C for single cell sequencing
Parse Biosciences has announced a significant milestone in their funding journey, securing a total of $50 million through a Series C equity raise and a ... Read More
Galecto raises $64m to develop fibrosis and cancer treatments
Galecto, a Danish biotech company, has raised $64 million in an equity financing round, for developing novel treatments for fibrosis and cancer. Led by Soleus ... Read More